In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefixime anhydrous, (E)- Drug Master File in Korea (Cefixime anhydrous, (E)- KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefixime anhydrous, (E)-. The MFDS reviews the Cefixime anhydrous, (E)- KDMF as part of the drug registration process and uses the information provided in the Cefixime anhydrous, (E)- KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefixime anhydrous, (E)- KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefixime anhydrous, (E)- API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefixime anhydrous, (E)- suppliers with KDMF on PharmaCompass.